David S - Search Results

1

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis.

Ben Djemaa S, David S, Hervé-Aubert K, Falanga A, Galdiero S, Allard-Vannier E, Chourpa I, Munnier E. Ben Djemaa S, et al. Among authors: david s. Eur J Pharm Biopharm. 2018 Oct;131:99-108. doi: 10.1016/j.ejpb.2018.07.024. Epub 2018 Jul 29. Eur J Pharm Biopharm. 2018. PMID: 30063968 Free article.

2

Non-viral nanosystems for systemic siRNA delivery.

David S, Pitard B, Benoît JP, Passirani C. David S, et al. Pharmacol Res. 2010 Aug;62(2):100-14. doi: 10.1016/j.phrs.2009.11.013. Epub 2009 Dec 17. Pharmacol Res. 2010. PMID: 20006707 Free article. Review.

3

siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.

David S, Resnier P, Guillot A, Pitard B, Benoit JP, Passirani C. David S, et al. Eur J Pharm Biopharm. 2012 Jun;81(2):448-52. doi: 10.1016/j.ejpb.2012.02.010. Epub 2012 Feb 21. Eur J Pharm Biopharm. 2012. PMID: 22381204 Free article.

4

EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.

Resnier P, David S, Lautram N, Delcroix GJ, Clavreul A, Benoit JP, Passirani C. Resnier P, et al. Among authors: david s. Int J Pharm. 2013 Oct 1;454(2):748-55. doi: 10.1016/j.ijpharm.2013.04.001. Epub 2013 Apr 10. Int J Pharm. 2013. PMID: 23583841

5

Use of experimental design methodology for the development of new magnetic siRNA nanovectors (MSN).

David S, Marchais H, Hervé-Aubert K, Bedin D, Garin AS, Hoinard C, Chourpa I. David S, et al. Int J Pharm. 2013 Oct 1;454(2):660-7. doi: 10.1016/j.ijpharm.2013.05.051. Epub 2013 May 31. Int J Pharm. 2013. PMID: 23726903

6

Modelling the response surface to predict the hydrodynamic diameters of theranostic magnetic siRNA nanovectors.

David S, Marchais H, Bedin D, Chourpa I. David S, et al. Int J Pharm. 2015 Jan 15;478(1):409-415. doi: 10.1016/j.ijpharm.2014.11.061. Epub 2014 Nov 28. Int J Pharm. 2015. PMID: 25437114

7

Novel alginate-based nanocarriers as a strategy to include high concentrations of hydrophobic compounds in hydrogels for topical application.

Nguyen HT, Munnier E, Souce M, Perse X, David S, Bonnier F, Vial F, Yvergnaux F, Perrier T, Cohen-Jonathan S, Chourpa I. Nguyen HT, et al. Among authors: david s. Nanotechnology. 2015 Jan 26;26(25):255101. doi: 10.1088/0957-4484/26/25/255101. Epub 2015 Jun 2. Nanotechnology. 2015. PMID: 26033822

8

Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics.

Bruniaux J, Djemaa SB, Hervé-Aubert K, Marchais H, Chourpa I, David S. Bruniaux J, et al. Among authors: david s. Int J Pharm. 2017 Nov 5;532(2):660-668. doi: 10.1016/j.ijpharm.2017.05.022. Epub 2017 May 12. Int J Pharm. 2017. PMID: 28506802 Free article.

9

siRNA delivery system based on magnetic nanovectors: Characterization and stability evaluation.

Abdelrahman M, Douziech Eyrolles L, Alkarib SY, Hervé-Aubert K, Ben Djemaa S, Marchais H, Chourpa I, David S. Abdelrahman M, et al. Among authors: david s. Eur J Pharm Sci. 2017 Aug 30;106:287-293. doi: 10.1016/j.ejps.2017.05.062. Epub 2017 Jun 1. Eur J Pharm Sci. 2017. PMID: 28579004 Free article.

10

Versatile electrostatically assembled polymeric siRNA nanovectors: Can they overcome the limits of siRNA tumor delivery?

Ben Djemaa S, Munnier E, Chourpa I, Allard-Vannier E, David S. Ben Djemaa S, et al. Among authors: david s. Int J Pharm. 2019 Aug 15;567:118432. doi: 10.1016/j.ijpharm.2019.06.023. Epub 2019 Jun 11. Int J Pharm. 2019. PMID: 31199995 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,200 results

Search Page

Filters